ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,453Medicare Part D Prescriptions Filled, Including Refills

Rank: 504 out of 6969

$664K Total Retail Price of All Prescriptions

Rank: 325 out of 6969

349 Patients Receiving at Least One Drug in Part D
35%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

30% of this provider’s 349 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

36% of this provider’s 349 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 3,277 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 731 203 S3 1 3
LISINOPRIL 406 205 2 2
SIMVASTATIN 289 141 3 1
OMEPRAZOLE 261 100 4 6
MORPHINE SULFATE ER 251 43 S2 5 90
CARISOPRODOL 210 0 R 6 69
OXYCODONE HCL 194 34 S2 7 117
LEVOTHYROXINE SODIUM 183 85 8 5
DEXILANT 175 42 9 110
PROAIR HFA 158 31 10 33
OXYCODONE-ACETAMINOPHEN 157 42 S2 11 135
HYDROCHLOROTHIAZIDE 152 80 12 8
ATORVASTATIN CALCIUM 152 56 12 11
ZOLPIDEM TARTRATE 144 29 14 16
NAPROXEN 143 31 15 62
GABAPENTIN 143 16 15 17
CYMBALTA 137 29 17 72
METFORMIN HCL 128 74 18 7
FUROSEMIDE 124 93 19 10
BACLOFEN 124 46 19 86
ADVAIR DISKUS 116 49 21 45
WARFARIN SODIUM 107 47 22 20
FENTANYL 102 12 S2 23 113
NEXIUM 95 32 24 52
AMLODIPINE BESYLATE 95 60 24 4
IBUPROFEN 94 17 26 29
TRAZODONE HCL 90 0 27 47
METOPROLOL TARTRATE 84 53 28 13
ACETAMINOPHEN-CODEINE 83 52 S3 29 73
CELEBREX 75 51 30 67
POTASSIUM CHLORIDE 75 48 30 30
AMITRIPTYLINE HCL 74 35 R 32 87
LOVASTATIN 73 33 33 15
ENALAPRIL MALEATE 73 20 33 56
VENTOLIN HFA 71 23 35 125
KLOR-CON 8 66 46 36 104
SPIRIVA 65 35 37 66
SERTRALINE HCL 62 13 38 38
ATENOLOL 61 0 39 9
ROPINIROLE HCL 60 20 40 162
VERAPAMIL ER 57 26 41 133
LANTUS 57 40 41 50
CYCLOBENZAPRINE HCL 56 13 R 43 130
SINGULAIR 55 13 44 84
PHENYTOIN SODIUM EXTENDED 54 22 45 169
OXYCONTIN 53 0 S2 46 193
TAMSULOSIN HCL 53 14 46 23
DIOVAN 52 0 48 26
CRESTOR 52 32 48 39
CARVEDILOL 52 0 48 25
LIPITOR 52 0 48 89
LOSARTAN POTASSIUM 50 0 52 12
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.